Validating novel mutations of patients with Fanconi anemia-‘like’ phenotype using CRISPR/Cas9
Lianne Vriend (VUmc)

A CRISPR toolbox to study cell state transitions in cancer
Johan van Nes (AMC)

Mitigating risk of off-target effects when using CRISPR genome editing
Mirko Vanetti (IDT)

Thursday 5 April 2018
AMC C1-214 (Wertheim zaal), 15:00
Hosted by Daniël Warmerdam
crispr@amsterdamumc.nl